Literature DB >> 3359105

The effect of dantrolene sodium on the discharge of alpha and gamma motoneurones to the soleus muscle in the decerebrate rat.

R Farquhar1, N J Part.   

Abstract

1. The effects of intravenous infusion of the direct acting muscle relaxant, dantrolene sodium (5 mg kg-1), on tension, integrated EMG, soleus muscle motor unit discharge frequency and gamma nerve fibre discharge were measured in the decerebrate rat. 2. Dantrolene sodium did not have any detectable direct effect upon the discharge of the gamma nerve fibres. 3. The soleus muscle of the decerebrate preparations exhibited spontaneous tension and reflex responses. 4. With the muscle held at constant length, dantrolene sodium caused an increase in the integrated EMG in 15 out of 18 experiments and a decrease in muscle tension in 15 out of 17. The results from these experiments showed great variability. 5. Dantrolene sodium caused a slight reduction in the tension response to tonic stretch; this was accompanied by an increase in the integrated EMG. 6. Dantrolene sodium also caused a shift in the relationship between tension and integrated EMG during the phasic component of the stretch reflex, with a greater integrated EMG being associated with a reduced tension. 7. Motor unit discharge frequencies were found to increase but not sufficiently to overcome the action of dantrolene sodium. It is concluded that motor unit recruitment must play an important role in the compensation for the muscle weakening action of dantrolene sodium.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3359105      PMCID: PMC1853791          DOI: 10.1111/j.1476-5381.1988.tb11429.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  14 in total

1.  Some observations on the efferent innervation of rat soleus muscle spindles.

Authors:  B L Andrew; G C Leslie; N J Part
Journal:  Exp Brain Res       Date:  1978-03-15       Impact factor: 1.972

2.  Effects of dantrolene sodium on respiratory and other muscles and on respiratory parameters in the anaesthetised cat.

Authors:  W C Bowman; J Houston; H H Khan; I W Rodger
Journal:  Eur J Pharmacol       Date:  1979-05-01       Impact factor: 4.432

3.  Excitation-contraction uncoupling in skeletal muscle by dantrolene sodium.

Authors:  K O Ellis; S H Bryant
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1972       Impact factor: 3.000

4.  Terminals of single Ia fibers: distribution within a pool of 300 homonymous motor neurons.

Authors:  L M Mendell; E Henneman
Journal:  Science       Date:  1968-04-05       Impact factor: 47.728

5.  Properties of fast and slow motor units in hind limb and tail muscles of the rat.

Authors:  B L Andrew; N J Part
Journal:  Q J Exp Physiol Cogn Med Sci       Date:  1972-04

6.  Cooperative study for assessing the effects of a pharmacological agent on spasticity.

Authors:  A W Monster; R Herman; S Meeks; J McHenry
Journal:  Am J Phys Med       Date:  1973-08

7.  Servo-regulated electromagnetic system for muscle stretch and vibration.

Authors:  R M Reinking; D G Stuart
Journal:  Am J Phys Med       Date:  1974-02

8.  Effects of intravenous dantrolene sodium on respiratory and cardiovascular functions.

Authors:  K O Ellis; F L Wessels; J F Carpenter
Journal:  J Pharm Sci       Date:  1976-09       Impact factor: 3.534

9.  Autogenetic reflex action on to gamma motoneurones by stretch of triceps surae in the decerebrated cat.

Authors:  P H Ellaway; J R Trott
Journal:  J Physiol       Date:  1978-03       Impact factor: 5.182

10.  How is ventilation maintained in the presence of the muscle relaxant, dantrolene sodium? A study in the anaesthetized rat.

Authors:  R Farquhar; G C Leslie; N J Part
Journal:  Br J Pharmacol       Date:  1986-05       Impact factor: 8.739

View more
  1 in total

1.  The effect of EU4093 (azumolene sodium) on the contraction of intrafusal muscle in the soleus muscle of the anaesthetized rat.

Authors:  G C Leslie; N J Part
Journal:  Br J Pharmacol       Date:  1989-08       Impact factor: 8.739

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.